Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BRM421
DRUG
2 trials
Sponsors
BRIM Biotechnology Inc.
Conditions
Dry Eye Syndrome
Phase 2
Safety and Efficacy of BRM421 for Dry Eye Syndrome
Completed
NCT03066219
BRIM Biotechnology Inc.
Dry Eye Syndrome
Start: 2017-02-07
End: 2017-06-28
Updated: 2026-05-01
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Completed
NCT04343287
BRIM Biotechnology Inc.
Dry Eye Syndrome
Start: 2020-01-15
End: 2020-06-23
Updated: 2026-05-01